Labcorp Holdings Inc. (LH) Financials

LH Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 19.1 billion 10.3 billion
Dec. 31, 2025 18.4 billion 9.8 billion
Sept. 30, 2025 18.3 billion 9.5 billion
June 30, 2025 18.1 billion 9.6 billion

LH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 70.5 million 31.7 million
Dec. 31, 2025 490.3 million 29.7 million
Sept. 30, 2025 280.5 million 29.2 million
June 30, 2025 542.7 million 34.1 million

LH Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 278.0 million
Dec. 31, 2025 164.9 million
Sept. 30, 2025 261.1 million
June 30, 2025 238.3 million

LH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 981.1 million 6.6 billion -
Dec. 31, 2025 532.3 million 5.8 billion 745.6 million
Sept. 30, 2025 598.1 million 5.8 billion 756.3 million
June 30, 2025 647.3 million 5.1 billion 969.1 million

LH Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 82.9 million
Dec. 31, 2025 83.2 million
Sept. 30, 2025 83.7 million
June 30, 2025 84.1 million

LH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 121.0 million - 551.0 million -
Dec. 31, 2025 123.9 million - 538.6 million -
Sept. 30, 2025 106.7 million - 552.4 million -
June 30, 2025 77.9 million - 579.3 million -

LH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 3.5 billion 2.6 billion
Dec. 31, 2025 3.5 billion 2.6 billion
Sept. 30, 2025 3.6 billion 2.5 billion
June 30, 2025 3.5 billion 2.5 billion

LH Revenue by Segment
Graph available only for paid members. Upgrade to see it.

LH

Price: $279.40

52 week price:
241.81
293.72

Dividend Yield: 1.00%

5-year range yield:
0.99%
1.49%

Forward Dividend Yield: 1.03%

Payout Ratio: 53.43%

Payout Ratio Range:
-36.56%
760.00%

Dividend Per Share: 2.88 USD

Earnings Per Share: 11.28 USD

P/E Ratio: 22.78

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 347600

Ebitda: 501.8 million

Market Capitalization: 23.5 billion

Average Dividend Frequency: 4

Years Paying Dividends: 5

DGR3: 30.00%

Links: